Matthew Love, MD, on optimizing outcomes with the SURE procedure for kidney stones

At the 2025 LUGPA Annual Meeting, Matthew A. Love, MD, presented a video on Steerable Ureteroscopic Renal Stone Evacuation (SURE), a novel approach to treating kidney stones using the CVAC device.

In a recent interview with Urology Times®, Love noted that this “all-in-one” approach can improve stone-free rates and reduce the need for repeat procedures. However, he also emphasized the importance of understanding the device’s safety features to optimize outcomes and minimize complications.

Love is a urologist at the Urology Group in Hamilton, Ohio.

During the discussion, Love touched on efficiency advantages with this approach. Compared with standard ureteroscopy, the CVAC device has demonstrated shorter operative times, particularly for complex stones or those located in multiple calyces, and may even serve as an alternative to PCNL in select cases, he explained. He also noted that data have suggested utility for stones as small as 7 mm, supporting operating room and ambulatory surgery center efficiencies.

Regarding safety, the device’s internal fluid management system is designed to reduce intrarenal pressures, temperatures, and potential sepsis risk when used appropriately. The key considerations, according to Love, involve recognizing and addressing scope clogs and monitoring indicators such as tactile feedback, unusual sounds, visual cues, and flow patterns. Increasing surgeon familiarity with the device helps minimize complications and optimize outcomes.